Moshe Flashner-Barak

This inventor holds 11 USPTO granted patents and 1 EPO patent. Top assignees: Teva Pharmaceutical Industries Limited, Hadasit Medical Research Services and Development Ltd.. Active years: 2002-2020.

USPTO Granted Patents = 11

% Patents Active = 18.2

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 130(Granted Patents)

Company Filing History:

10 out of 505

Teva Pharmaceutical Industries Limited

patents

1 out of 180

Hadasit Medical Research Services and Development Ltd.

patents

Years Active: 2002-2020

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10525009 - Formulations of 6-mercaptopurine (2020-01-07),

2. 9375403 - Formulations of 6-mercaptopurine (2016-06-28),

3. 9180097 - Formulations of 6-mercaptopurine (2015-11-10),

4. 9107832 - Risperidone microparticles formed by sublimation (2015-08-18),

5. 8663703 - Drug microparticles, processes of preparing them and a drug delivery vehicle comprising them (2014-03-04),

6. 8653060 - Formulations of 6-mercaptopurine (2014-02-18),

7. 8188067 - Formulations of 6-mercaptopurine (2012-05-29),

8. 7579333 - Therapy using a combination of raloxifene and alendronate (2009-08-25),

9. 6881420 - Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation (2005-04-19),

10. 6569459 - Method of administration of paclitaxel-plasma protein formulation (2003-05-27),

11. 6476006 - Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates (2002-11-05),

Title: The Innovations of Moshe Flashner-Barak

Introduction

Moshe Flashner-Barak is a notable inventor based in Petach Tikva, Israel. He has made significant contributions to the field of pharmaceuticals, particularly through his work on formulations of 6-mercaptopurine. With a total of 11 patents to his name, Flashner-Barak has demonstrated a commitment to enhancing drug efficacy and bioavailability.

Latest Patents

One of his latest patents focuses on improved formulations of 6-mercaptopurine. This invention provides formulations that exhibit better bioavailability and faster dissolution compared to previous versions. Such advancements are crucial in ensuring that patients receive the most effective treatment possible.

Career Highlights

Throughout his career, Moshe Flashner-Barak has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Teva Pharmaceutical Industries Limited and Hadasit Medical Research Services and Development Ltd. His work in these organizations has allowed him to contribute to significant advancements in medical research and drug development.

Collaborations

Flashner-Barak has collaborated with esteemed colleagues, including E Itzhak Lerner and Hans Keegstra. These partnerships have further enriched his research and innovation efforts, leading to impactful developments in the pharmaceutical sector.

Conclusion

Moshe Flashner-Barak's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of effective medical treatments.